SCHEMBL5477145

SCHEMBL5477145

NS(=O)(=O)NCCCCC(NC(=O)Nc1ccccc1)C(=O)Nc1cccc2cccnc12

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 15/20 0.62
HDAC6 Q9UBN7 12/20 0.62
MEN1 O00255 1/20 0.56
MAPT P10636 1/20 0.56
KMT2A Q03164 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
HDAC4 P56524 9/20 0.51
MEF2D Q14814 2/20 0.51
EP300 Q09472 1/20 0.51
HDAC3 O15379 4/20 0.48
HDAC7 Q8WUI4 4/20 0.48
HDAC2 Q92769 4/20 0.48
HDAC10 Q969S8 4/20 0.48
HDAC11 Q96DB2 4/20 0.48
HDAC8 Q9BY41 4/20 0.48
HDAC9 Q9UKV0 4/20 0.48
HDAC5 Q9UQL6 4/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5477143 1.00 HDAC1 (0.62) HDAC1HDAC6MEN1MAPTKMT2A
SCHEMBL5455396 0.90 HDAC6 (0.64) HDAC1HDAC6HDAC4MEF2DEP300
SCHEMBL5328643 0.89 HDAC1 (0.59) HDAC1HDAC6HDAC4MEF2DEP300
SCHEMBL5328648 0.89 HDAC1 (0.59) HDAC1HDAC6HDAC4MEF2DEP300
SCHEMBL5470387 0.87 HDAC6 (0.63) HDAC1HDAC6HDAC4MEF2DEP300
SCHEMBL5470402 0.87 HDAC6 (0.63) HDAC1HDAC6HDAC4MEF2DEP300
SCHEMBL5465010 0.85 HDAC6 (0.61) HDAC1HDAC6MAPTSMN1; SMN2HDAC4
SCHEMBL5465004 0.85 HDAC6 (0.61) HDAC1HDAC6MAPTSMN1; SMN2HDAC4
SCHEMBL8113524 0.84 HDAC1 (0.79) HDAC1HDAC6HDAC4HDAC3HDAC7
SCHEMBL8106259 0.82 HDAC6 (0.53) HDAC1HDAC6HDAC4MEF2DEP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS METHYLGENE INC. (CA) 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293530-A1 SULFAMIDE AND SULFAMATE DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HAT1 HDAC1 1/4885HDAC6 11/4885MEN1 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.